12.87
price down icon1.08%   -0.14
after-market After Hours: 12.90 0.03 +0.23%
loading
Delcath Systems Inc stock is traded at $12.87, with a volume of 388.88K. It is down -1.08% in the last 24 hours and up +9.81% over the past month. Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$13.01
Open:
$13
24h Volume:
388.88K
Relative Volume:
0.84
Market Cap:
$444.29M
Revenue:
$90.44M
Net Income/Loss:
$561.00K
P/E Ratio:
2,145.00
EPS:
0.006
Net Cash Flow:
$19.19M
1W Performance:
-4.53%
1M Performance:
+9.81%
6M Performance:
+23.51%
1Y Performance:
+13.49%
1-Day Range:
Value
$12.85
$13.14
1-Week Range:
Value
$12.74
$13.70
52-Week Range:
Value
$8.12
$13.74

Delcath Systems Inc Stock (DCTH) Company Profile

Name
Name
Delcath Systems Inc
Name
Phone
(518) 743-8892
Name
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Name
Employee
156
Name
Twitter
@delcathsystems
Name
Next Earnings Date
2026-08-05
Name
Latest SEC Filings
Name
DCTH's Discussions on Twitter

Compare DCTH vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
DCTH icon
DCTH
Delcath Systems Inc
12.87 449.13M 90.44M 561.00K 19.19M 0.006
ABT icon
ABT
Abbott Laboratories
92.11 163.61B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
331.45 126.42B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
83.57 107.36B 36.36B 4.84B 5.43B 3.7261
BSX icon
BSX
Boston Scientific Corp
44.65 66.54B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
91.79 53.09B 6.30B 1.07B 1.09B 1.8406

Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-28-24 Initiated Craig Hallum Buy
May-14-24 Initiated Stephens Overweight
Jul-26-22 Resumed Canaccord Genuity Buy
Dec-10-21 Initiated H.C. Wainwright Buy
Mar-09-21 Initiated Canaccord Genuity Buy
Jan-05-21 Initiated BTIG Research Buy
Jun-01-20 Initiated Laidlaw Buy
View All

Delcath Systems Inc Stock (DCTH) Latest News

pulisher
Jul 11, 2026

Understanding Momentum Shifts in (DCTH) - Stock Traders Daily

Jul 11, 2026
pulisher
Jul 10, 2026

Is Delcath Systems Inc (DCTH) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus

Jul 10, 2026
pulisher
Jul 10, 2026

CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21 - Moomoo

Jul 10, 2026
pulisher
Jul 09, 2026

Delcath Systems begins Phase 2 breast cancer trial - grafa.com

Jul 09, 2026
pulisher
Jul 09, 2026

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - BioSpace

Jul 09, 2026
pulisher
Jul 09, 2026

Delcath doses first patient in breast cancer trial in Milan - Investing.com

Jul 09, 2026
pulisher
Jul 07, 2026

$13.513 | Delcath Systems, Inc. Common Stock (DCTH) Stock Price Today - Binance

Jul 07, 2026
pulisher
Jul 06, 2026

Delcath Systems (DCTH) Gains 2.12% as Stock Approaches Key Resistance LevelGEX Level - DonanımHaber

Jul 06, 2026
pulisher
Jul 06, 2026

DCTH Q1 2026 Earnings: EPS Surprises to the Upside as Company Advances Core PipelineEarnings Per Share - dars.gov.et

Jul 06, 2026
pulisher
Jul 04, 2026

DCTHDelcath Systems Inc Options - Finviz

Jul 04, 2026
pulisher
Jul 01, 2026

Price to sales forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView

Jul 01, 2026
pulisher
Jun 30, 2026

Avoiding Lag: Real-Time Signals in (DCTH) Movement - Stock Traders Daily

Jun 30, 2026
pulisher
Jun 29, 2026

Delcath Systems, Inc.(NasdaqCM:DCTH) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Price to book forward of Delcath Systems, Inc. – SWB:DV3R - TradingView

Jun 29, 2026
pulisher
Jun 28, 2026

Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value-Defensive Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Price to earnings forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of Delcath Systems, Inc. – SWB:DV3R - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to EBITDA forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Mettler-Toledo (MTD) soars 3.3%: Is further upside left in the stock? - MSN

Jun 28, 2026
pulisher
Jun 28, 2026

Delcath Systems (DCTH) Gains 5% as Stock Nears Key Resistance LevelIchimoku Cloud - dars.gov.et

Jun 28, 2026
pulisher
Jun 26, 2026

Delcath Systems, Inc. Actuals & Estimates (FWB:DV3R) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Delcath Systems, Inc. Actuals & Estimates (NASDAQ:DCTH) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Delcath Systems, Inc. Actuals & Estimates (LS:A2PT5P) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

DCTH Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Delcath Systems Inc (DCTH) Institutional Confidence - TradingKey

Jun 25, 2026
pulisher
Jun 23, 2026

Delcath Systems (DCTH) Surges 5.6% on Above-Average Volume, Tests Key ResistanceChart Pattern Alerts - dars.gov.et

Jun 23, 2026
pulisher
Jun 23, 2026

Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN

Jun 23, 2026
pulisher
Jun 22, 2026

Delcath Systems Inc (DCTH) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 22, 2026
pulisher
Jun 20, 2026

Delcath Systems (DCTH) Dips 2% as Stock Approaches Critical SupportHigh Volume Stocks - dars.gov.et

Jun 20, 2026
pulisher
Jun 18, 2026

Delcath Systems Inc (DCTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Delcath Systems Inc (DCTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Delcath Systems Inc (DCTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Delcath Systems Inc (DCTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Delcath Systems Inc (DCTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Delcath Systems Inc (DCTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Delcath Systems (DCTH) Rallies 3.7%—Testing Key Resistance at $12.57Covered Call Trade - dars.gov.et

Jun 17, 2026
pulisher
Jun 16, 2026

Q1 2026 Delcath Systems Inc Earnings Call Transcript - GuruFocus

Jun 16, 2026
pulisher
Jun 16, 2026

Delcath Systems Inc (DCTH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 16, 2026
pulisher
Jun 13, 2026

Delcath Systems (DCTH) Q1 2026 Earnings: Narrower-than-Expected Losses Amid Clinical ProgressEarnings Season Preview - dars.gov.et

Jun 13, 2026
pulisher
Jun 10, 2026

Delcath Systems (DCTH) Slips 1.5% as Shares Test Critical Support Near $11NHNL Ratio - DonanımHaber

Jun 10, 2026
pulisher
Jun 08, 2026

Delcath Systems, Inc. - MLQ.ai

Jun 08, 2026
pulisher
Jun 06, 2026

Delcath Systems, Inc. Stock 12‑Month Price Target Cut to $20.83, Implies 95% Upside - TradingView

Jun 06, 2026
pulisher
Jun 05, 2026

European cancer guidelines add Delcath liver therapy for eye melanoma - Stock Titan

Jun 05, 2026
pulisher
Jun 04, 2026

Delcath therapy included in European uveal melanoma guidelines - Investing.com

Jun 04, 2026
pulisher
May 29, 2026

FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC - Quantisnow

May 29, 2026
pulisher
May 28, 2026

(DCTH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 28, 2026
pulisher
May 28, 2026

Abbott’s $21bn Bet on Exact Sciences Takes Center Stage at ASCO 2026 - Citeline News & Insights

May 28, 2026
pulisher
May 27, 2026

Delcath Systems Q1 2026 Earnings: Narrowed Loss Surprises, Stock AdvancesCore Business Growth - newsline.com

May 27, 2026
pulisher
May 26, 2026

Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts - BioSpace

May 26, 2026

Delcath Systems Inc Stock (DCTH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Delcath Systems Inc Stock (DCTH) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Sylvester John Richard
Director
Nov 21 '25
Buy
8.89
4,386
38,992
14,936
MICHEL GERARD J
CHIEF EXECUTIVE OFFICER
Nov 11 '25
Buy
8.53
11,500
98,049
330,834
ZBH ZBH
$94.08
price up icon 3.00%
STE STE
$217.05
price up icon 0.49%
PHG PHG
$27.34
price down icon 0.22%
$76.35
price up icon 1.85%
$65.31
price up icon 0.94%
EW EW
$91.79
price down icon 0.46%
Cap:     |  Volume (24h):